skip to the content

References: precise VEGF inhibition by Avastin limits toxicity

  1. Kozloff M, Hainsworth J, Badarinath S, et al. Presented at: 2007 Gastrointestinal Cancers Symposium; 19–21 January 2007; Orlando Fl. Abstract 375; poster presentation. Available at: http://www.asco.org.
  2. Van Cutsem E, Rivera F, Berry S, et al. Ann Oncol 2009;20:1842–7.
  3. Wu Y, Jiang G, Reck M, et al. Proceedings of the International Union Against Cancer (UICC), Geneva, Switzerland August 2008 2008;POS-B174.
  4. Smith IE, Biganzoli L, Cortés-Funes H, et al. Cancer Res 2009;69(Suppl.):292s (Abstract 4118 and associated poster presentation).
  5. Avastin Summary of Product Characteristics. Available at: http://www.emea.europa.eu/humandocs/Humans/EPAR/avastin/avastin.htm.
  6. Kamba T, McDonald DM. Br J Cancer 2007;96:1788–95.
  7. Verheul HMW, Pinedo HM. Nat Rev Cancer 2007;7:475–85.
  8. Gordon MS, Cunningham D. Oncology 2005;69(Suppl. 3):25–33.
  9. Escudier B, Pluzanska A, Koralewski P, et al. Lancet 2007;370:2103–11.
  10. Miller K, Wang M, Gralow J, et al. N Engl J Med 2007;357:2666–76.
  11. Reck M, von Pawel J, Zatloukal P, et al. J Clin Oncol 2009;27:1227–34.
  12. Kollmannsberger C, Soulieres D, Wong R, et al. Can Urol Assoc J 2007;1(Issue 2 Suppl.):S41–54.